Preoperative mean corpuscular hemoglobin affecting long‑term outcomes of hepatectomized patients with hepatocellular carcinoma

  • Authors:
    • Pinzhu Huang
    • Chunhong Liu
    • Binkui Li
    • Yun Zheng
    • Ruhai Zou
    • Jun Huang
    • Zemin Hu
    • Yunfei Yuan
  • View Affiliations

  • Published online on: December 10, 2015     https://doi.org/10.3892/mco.2015.705
  • Pages: 229-236
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Pretreatment anemia has been reported to be associated with survival in several solid tumor types. In terms of survival, only limited data on the hemoglobin (HGB) level in hepatocellular carcinoma (HCC) have been published and no data on mean corpuscular hemoglobin (MCH) level in HCC is available. The present study sought to examine the role of HGB and MCH levels in predicting long‑term survival of patients with HCC who undergo resection. A retrospective study of 399 consecutive patients (1987‑1994) who underwent hepatic resection for HCC in Sun Yat‑Sen University Cancer Centre was performed. Serum HGB and MCH levels were examined preoperatively, and their prognostic capabilities were evaluated by Cox's proportional hazard model. Among the whole cohort, the HGB level appeared to be positively correlated with the MCH level (P<0.001). Survival analysis revealed that low levels of HGB (P=0.007) and MCH (P<0.001) were correlated with shorter overall survival (OS). Multivariate analysis revealed that MCH level was independently associated with OS (P<0.001), however, not HGB (P=0.278). In addition, 129 patients with large HCC (≥10 cm) tended to have a poorer OS (P<0.001) when compared with patients with smaller HCC. On subanalysis of patients with large HCC, MCH level also retained its stratified significance (P=0.001). Along with common clinicopathological variables, these results suggested that MCH, however, not HGB, may be useful in assessing prognosis for patients with HCC who undergo hepatectomy, particularly in identifying patients with large HCC who are most likely benefit from resection.
View Figures
View References

Related Articles

Journal Cover

February 2016
Volume 4 Issue 2

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Huang, P., Liu, C., Li, B., Zheng, Y., Zou, R., Huang, J. ... Yuan, Y. (2016). Preoperative mean corpuscular hemoglobin affecting long‑term outcomes of hepatectomized patients with hepatocellular carcinoma. Molecular and Clinical Oncology, 4, 229-236. https://doi.org/10.3892/mco.2015.705
MLA
Huang, P., Liu, C., Li, B., Zheng, Y., Zou, R., Huang, J., Hu, Z., Yuan, Y."Preoperative mean corpuscular hemoglobin affecting long‑term outcomes of hepatectomized patients with hepatocellular carcinoma". Molecular and Clinical Oncology 4.2 (2016): 229-236.
Chicago
Huang, P., Liu, C., Li, B., Zheng, Y., Zou, R., Huang, J., Hu, Z., Yuan, Y."Preoperative mean corpuscular hemoglobin affecting long‑term outcomes of hepatectomized patients with hepatocellular carcinoma". Molecular and Clinical Oncology 4, no. 2 (2016): 229-236. https://doi.org/10.3892/mco.2015.705